By Katherine Hamilton
Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers to create a newly formed company called VB Spine.
The medical technology company said Tuesday the New York City-based Viscogliosi Brothers specializes in neuro-musculoskeletal treatments.
The transaction for the U.S. business is set to close in the first half of 2025.
"We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an independent company," said Stryker Chief Executive and Chair Kevin Lobo.
Once the sale closes, VB Spine would become a strategic partner to Stryker with access to Mako Spine and Copilot.
The agreement includes a binding offer to acquire Stryker's spinal implants business in France.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
January 28, 2025 16:31 ET (21:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.